in the last 5 years, the russian pharmaceutical market has increased on average by 12% in rubles...
TRANSCRIPT
OUR PHARMA
Sergey ShulyakGeneral DirectorDSM Group
St. Petersburg20 May 2015
In the last 5 years, the Russian pharmaceutical market has increased on average by 12% in rubles
Source: DSM Group, audit of Russian pharmaceutical market
The largest decline in the market was in USD
Source: DSM Group, audit of Russian pharmaceutical market
Seasonal disease is an anti-crisis tool
In January-March:
The growth in rubles: 25%The increase in packages: 3%
Source: DSM Group, audit of Russian pharmaceutical market
The results of the first quarter of 2015: inflation is 10%
Source: DSM Group, audit of Russian pharmaceutical market
In April, price growth has stopped
Source: DSM Group, audit of Russian pharmaceutical market
50% of the market is under price regulation
Source: DSM Group, audit of Russian pharmaceutical market
OTC medicines from the list of essential drugs take more then 50% in packages in Retail segment
Source: DSM Group, audit of Russian pharmaceutical market
In the state segment, essential drugs with a price more than 500 rubles account for over 80%
Source: DSM Group, audit of Russian pharmaceutical market
Essential drugs for a lifelong term
Source: DSM Group, audit of Russian pharmaceutical market
Total sales of the top 10 "incident" brands of essential drugs declined by 5.2 million packages
Source: DSM Group, audit of Russian pharmaceutical market
“Excluded INN” in 2015 had better luck
The weighted average price, rubles. Jan-15 Feb-15 Mar-15 Increase
ACTIVATED CHARCOAL 11,4 12,6 15,8 39%
POSTINOR 235,5 235,0 235,6 0%
BISEPTOL 78,3 79,9 80,8 3%
BEROTEC 308,5 308,6 294,9 -4%
ASCORBIC ACID WITH GLUCOSE 6,8 7,3 8,3 22%
Source: DSM Group, audit of Russian pharmaceutical market
Advertising is the main tool for promoting drugs
Source : TNS Russia, TV Index
7 companies out of the 25 advertisers are pharmaceutical manufacturing companies
Source : TNS Russia, TV Index
TOP- advertisers on the expenses on advertising in the media in 2014
Rank Advertiser Budget rubles. (% Of the
total cost)4 NOVARTIS 2,2%7 RECKITT BENCKISER 1,7%
10 JOHNSON & JOHNSON 1,5%13 EVALAR 1,3%16 OTCPHARM 1,2%17 SANOFI AVENTIS 1,2%22 BAYER 0,9%
Pharmaceutical companies costs of TV advertising are growing in the volume of the total cost of TV advertising
Source : TNS Russia, TV Index
TOP TV advertisers in January-September 2014
Rank Advertiser The increase in 2013 (1-3q)5 RECKITT BENCKISER 8%6 NOVARTIS 22%9 JOHNSON & JOHNSON 30%
13 SANOFI AVENTIS 42%14 OTCPHARM 15%18 BAYER 16%19 EVALAR 18%
Only 2% of drug assortment is represented in more than 80% pharmacies
Source: Pharmacy penetration, 4,000 points
The commercial market turns about 15 000 SKU drugs.
Sales of drugs with a penetration of 40-80% are more then 60%
Source: Pharmacy penetration, 4,000 points
The presence of drugs in the pharmacy is a prerequisite of successful advertising company
Source: Pharmacy penetration, 4,000 points
The presence of drugs in the pharmacy is a prerequisite of successful advertising company
Source: Pharmacy penetration, 4,000 points
Forecast 2015: the market will grow by 12% in rubles
Source: DSM Group, audit of Russian pharmaceutical market
Forecast 2015 dollars, the market can return to 2010 level
Source: DSM Group, audit of Russian pharmaceutical market
RUSSIAN PHARMATo understand and forgive…
THANK YOU FOR YOUR ATTENTION
www.dsm.ru